Hepatic mitochondrial glutatathione depletion and progression of experimental alcoholic liver disease in rats
Hirano, T.; Kaplowitz, N.; Tsukamoto, H.; Kamimura, S.; Fernandezcheca, J.C.
Hepatology (Baltimore, Md.) 16(6): 1423-1427
1992
ISSN/ISBN: 0270-9139 Accession: 075706513
PDF emailed within 1 workday: $29.90
Related References
Hirano, T.; Kaplowitz, N.; Tsukamoto, H.; Kamimura, S.; Fernandez-Checa, J.C. 1992: Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats Hepatology 16(6): 1423-1427Hirano, T.; Kamimura, S.; Fernandez Checa, J.; Kaplowitz, N.; Tsukamoto, H. 1992: Selective depletion of hepatic mitochondrial GSH in progression of experimental alcoholic liver disease Hepatology 16(4 Part 2): 90A
Colell, A.; Garcia Ruiz, C.; Kaplowitz, N.; Fernandez Checa, J.C. 1998: Hepatic mitochondrial glutathione depletion and cytokine-mediated alcoholic liver disease Alcoholism Clinical and Experimental Research 22(3): 763-765
Lazarin, M.d.O.; Ishii-Iwamoto, E.L.; Yamamoto, N.S.; Constantin, R.P.; Garcia, R.ân.F.; da Costa, C.íl.E.M.; Vitoriano, A.d.S.; de Oliveira, M.C.; Salgueiro-Pagadigorria, C.L. 2011: Liver mitochondrial function and redox status in an experimental model of non-alcoholic fatty liver disease induced by monosodium L-glutamate in rats Experimental and Molecular Pathology 91(3): 687-694
Takahashi, H.; Geoffrion, Y.; Butler, K.W.; French, S.W. 1990: In vivo hepatic energy metabolism during the progression of alcoholic liver disease: a noninvasive 31P nuclear magnetic resonance study in rats Hepatology 11(1): 65-73
Fernández-Checa, J.C.; Hirano, T.; Tsukamoto, H.; Kaplowitz, N. 1993: Mitochondrial glutathione depletion in alcoholic liver disease Alcohol 10(6): 469-475
Fisher, C.D.; Lickteig, A.J.; Augustine, L.M.; Oude Elferink, R.P.J.; Besselsen, D.G.; Erickson, R.P.; Cherrington, N.J. 2009: Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats European Journal of Pharmacology 613(1-3): 119-127
Fernandezcheca, J.C.; Colell, A.; Garciaruiz, C. 2002: S-adenosyl-L-methionine and mitochondrial reduced glutathione depletion in alcoholic liver disease Role of S-Adenosyl-L-Methionine in the Treatment of Alcoholic Liver Disease (Bethesda, Md 2001-09) 27(3): 179-183
Fernández-Checa, Jé.C.; Colell, A.; García-Ruiz, C. 2002: S-Adenosyl-L-methionine and mitochondrial reduced glutathione depletion in alcoholic liver disease Alcohol 27(3): 179-183
Panes, J.; Pares, A.; Torra, M.; Jimenez, W.; Caballeria, J.; Torres, M.; Rodamilans, M.; Rodes, J. 1985: Evidence that zinc depletion may favor hepatic fibrogenesis in alcoholic liver disease Journal of Hepatology (Suppl 2): S300
Palma, E.; Riva, A.; Moreno, C.; Odena, G.; Mudan, S.; Manyakin, N.; Miquel, R.; Degré, D.; Trepo, E.; Sancho-Bru, P.; Altamirano, J.; Caballeria, J.; Zamalloa, A.; Menon, K.; Heaton, N.; Williams, R.; Bataller, R.; Chokshi, S. 2020: Perturbations in Mitochondrial Dynamics Are Closely Involved in the Progression of Alcoholic Liver Disease Alcoholism Clinical and Experimental Research 44(4): 856-865
Yamada, S. 1999: A pivotal role of activated hepatic macrophage in the progression of alcoholic liver disease Journal of Uoeh 21(1): 37-45
Ekstedt, M.; Franzén, L.E.; Holmqvist, M.; Bendtsen, P.; Mathiesen, U.L.; Bodemar, Göran.; Kechagias, S. 2009: Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease Scandinavian Journal of Gastroenterology 44(3): 366-374
Buko, V.; Kuzmitskaya, I.; Kirko, S.; Belonovskaya, E.; Naruta, E.; Lukivskaya, O.; Shlyahtun, A.; Ilyich, T.; Zakreska, A.; Zavodnik, I. 2019: Betulin attenuated liver damage by prevention of hepatic mitochondrial dysfunction in rats with alcoholic steatohepatitis Physiology International 106(4): 323-334
Liu, Y-Lin.; Reeves, H.L.; Burt, A.D.; Tiniakos, D.; McPherson, S.; Leathart, J.B.S.; Allison, M.E.D.; Alexander, G.J.; Piguet, A-Christine.; Anty, R.; Donaldson, P.; Aithal, G.P.; Francque, S.; Van Gaal, L.; Clement, K.; Ratziu, V.; Dufour, J-Francois.; Day, C.P.; Daly, A.K.; Anstee, Q.M. 2014: TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease Nature Communications 5: 4309
Peters, K.M.; Wilson, R.B.; Borradaile, N.M. 2018: Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis Current Opinion in Lipidology 29(5): 417-422
Heo, J.H.; Lee, S.R.; Jo, S.L.; Ko, J.-W.; Kwon, H.-J.; Hong, E.-J. 2021: Hepatic LKB1 Reduces the Progression of Non-Alcoholic Fatty Liver Disease via Genomic Androgen Receptor Signaling International Journal of Molecular Sciences 22(15)
Castro, P.Cenira.Senger.de.; Alberton, H.Caroline.Perussolo.; Pedroso, M.Lucia.Alves.; Morsoletto, D.Benatti.Gonçalves.; Pissaia Junior, A.; Ivantes, Cáudia.Alexandra.Pontes. 2019: Evaluation of Progression of Hepatic Fibrosis in a Group of Patients with Non-Alcoholic Fatty Liver Disease Accompanied for 10 Years Arquivos de Gastroenterologia 56(3): 256-260
Ryaboshapkina, M.; Hammar, Mårten. 2017: Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis Scientific Reports 7(1): 12361
Zeybel, M.üj.; Hardy, T.; Robinson, S.M.; Fox, C.; Anstee, Q.M.; Ness, T.; Masson, S.; Mathers, J.C.; French, J.; White, S.; Mann, J. 2015: Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease Clinical Epigenetics 7: 25